Tue, March 17, 2020

Stephen Willey Maintained (SPRO) at Strong Buy with Decreased Target to $21 on, Mar 17th, 2020

Stephen Willey of Stifel, Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $22 to $21 on, Mar 17th, 2020.

Stephen, nor any peers, have made any analyst calls on SPRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications